Author:
Lachâtre Marie,Launay Odile
Reference38 articles.
1. EMA. COVID-19 vaccines. european medicines Agency [en ligne]. 2022 [consulté le 23 juin 2022]. Disponible sur: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines-covid-19.
2. COVID-19 vaccine tracker and landscape [en ligne]. 2022 [consulté le 23 juin 2022]. Disponible sur: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
3. A Multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice;Freyn;Mol Ther J Am Soc Gene Ther,2020
4. Immunogenicity and protection efficacy of a naked self-replicating mRNA-based Zika virus vaccine;Zhong;Vaccines,2019
5. Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion;Bogers;J Infect Dis,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献